Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes

Jennifer L. Fisher,Amanda D. Clark,Emma F. Jones,Brittany N. Lasseigne

DOI: https://doi.org/10.1186/s40360-023-00727-1

2024-01-03

BMC Pharmacology and Toxicology

Abstract:Previous pharmacovigilance studies and a retroactive review of cancer clinical trial studies identified that women were more likely to experience drug adverse events (i.e., any unintended effects of medication), and men were more likely to experience adverse events that resulted in hospitalization or death. These sex-biased adverse events (SBAEs) are due to many factors not entirely understood, including differences in body mass, hormones, pharmacokinetics, and liver drug metabolism enzymes and transporters.

pharmacology & pharmacy,toxicology